These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1943985)

  • 1. [Serum level of beta-glucuronidase as potential indicator of disease activity in rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE)].
    Falkenbach A; Unkelbach U; Gottschalk R; Kaltwasser JP
    Med Klin (Munich); 1991 Sep; 86(9):465-8. PubMed ID: 1943985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serum concentration of hyaluronic acid in healthy populations and patients with rheumatoid arthritis--relationship to clinical disease activity of RA].
    Yoshinoya S; Mizoguchi Y; Hashimoto Y; Yamada A; Uchida S; Taniguchi A; Nishioka K; Miyamoto T
    Ryumachi; 1991 Aug; 31(4):381-90. PubMed ID: 1948454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis.
    Hepburn AL; Mason JC; Davies KA
    Rheumatology (Oxford); 2004 May; 43(5):547-54. PubMed ID: 14747618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The content of interleukin-1 beta in the blood serum of patients with systemic lupus erythematosus and rheumatoid arthritis].
    Ketlinskiĭ SA; Alekseeva TG; Perumov ND; Simbirtsev AS
    Ter Arkh; 1993; 65(12):51-4. PubMed ID: 8146772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical value of determining beta-glucuronidase and glycosaminoglycans in blood cells and biological fluids in patients with rheumatoid arthritis].
    Astakhova TA; Volkova ZI; Trofimova TM; Mul'diiarov PIa
    Ter Arkh; 1987; 59(4):62-7. PubMed ID: 3590007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of pregnenolone and 17-hydroxypregnenolone in patients with rheumatoid arthritis and systemic lupus erythematosus: relation to other adrenal hormones.
    Vogl D; Falk W; Dorner M; Schölmerich J; Straub RH
    J Rheumatol; 2003 Feb; 30(2):269-75. PubMed ID: 12563679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of ifn-inducible PROTEIN-10 relating to the activity of systemic lupus erythematosus.
    Narumi S; Takeuchi T; Kobayashi Y; Konishi K
    Cytokine; 2000 Oct; 12(10):1561-5. PubMed ID: 11023674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum cytidine deaminase as a measure of disease activity in rheumatoid arthritis and systemic lupus erythematosus.
    Skeith KJ; Wefuan J; Oswald R; Davis P
    J Rheumatol; 1993 Aug; 20(8):1309-15. PubMed ID: 8230010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum thrombomodulin in systemic lupus erythematosus and juvenile idiopathic arthritis.
    el-Gamal YM; Heshmat NM; el-Kerdany TH; Fawzy AF
    Pediatr Allergy Immunol; 2004 Jun; 15(3):270-7. PubMed ID: 15209962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
    Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
    J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity.
    Gabay C; Cakir N; Moral F; Roux-Lombard P; Meyer O; Dayer JM; Vischer T; Yazici H; Guerne PA
    J Rheumatol; 1997 Feb; 24(2):303-8. PubMed ID: 9034987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of soluble inducible costimulator ligand (ICOSL) in patients with systemic lupus erythematosus.
    Her M; Kim D; Oh M; Jeong H; Choi I
    Lupus; 2009 May; 18(6):501-7. PubMed ID: 19395451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible role of leptin in hypoandrogenicity in patients with systemic lupus erythematosus and rheumatoid arthritis.
    Härle P; Pongratz G; Weidler C; Büttner R; Schölmerich J; Straub RH
    Ann Rheum Dis; 2004 Jul; 63(7):809-16. PubMed ID: 15194576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indices.
    Szekanecz E; Szucs G; Szekanecz Z; Tarr T; Antal-Szalmás P; Szamosi S; Szántó J; Kiss E
    J Autoimmun; 2008 Dec; 31(4):372-6. PubMed ID: 18926664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health status in systemic lupus erythematosus compared to rheumatoid arthritis and healthy controls.
    Gilboe IM; Kvien TK; Husby G
    J Rheumatol; 1999 Aug; 26(8):1694-700. PubMed ID: 10451064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The level of the tumor necrosis factor in the blood serum of patients with systemic lupus erythematosus and rheumatoid arthritis].
    Prokop'ev AA; Alekseeva TG; Zimina ZV; Ketlinskiĭ SA
    Ter Arkh; 1993; 65(5):9-12. PubMed ID: 8036608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients.
    Lin SC; Chen KH; Lin CH; Kuo CC; Ling QD; Chan CH
    Eur J Clin Invest; 2007 Dec; 37(12):987-96. PubMed ID: 18036033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of anti-3-nitrotyrosine antibodies in the joint synovial fluid of patients with rheumatoid arthritis, osteoarthritis and systemic lupus erythematosus.
    Khan F; Siddiqui AA
    Clin Chim Acta; 2006 Aug; 370(1-2):100-7. PubMed ID: 16513103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased levels of autoantibodies against catalase and superoxide dismutase associated with oxidative stress in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Mansour RB; Lassoued S; Gargouri B; El Gaïd A; Attia H; Fakhfakh F
    Scand J Rheumatol; 2008; 37(2):103-8. PubMed ID: 18415766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
    Yajima N; Kasama T; Isozaki T; Odai T; Matsunawa M; Negishi M; Ide H; Kameoka Y; Hirohata S; Adachi M
    Arthritis Rheum; 2005 Jun; 52(6):1670-5. PubMed ID: 15934075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.